Ana Merz, MBA
About Ana Merz, MBA
Ana Merz, MBA, serves as the Vice President of Sales at BridgeBio, bringing extensive experience in the pharmaceutical industry, including leadership roles at Pharmacyclics and Sanofi. She has a strong background in sales and account management, having successfully launched multiple FDA approvals and received several awards for her performance.
Current Role at BridgeBio
Ana Merz serves as the Vice President of Sales at BridgeBio, a position she has held since 2023. In this role, she is responsible for overseeing sales strategies and initiatives within the organization. Her leadership is focused on driving sales performance and expanding the company's market presence.
Previous Experience in Pharmaceutical Sales
Ana Merz has extensive experience in the pharmaceutical industry. She worked at Pharmacyclics, an AbbVie Company, in various roles including Regional Sales Director for the South from 2018 to 2023, where she oversaw four Division Managers and 32 Hematology Sales Representatives. Prior to that, she held positions at Sanofi, Cephalon, and Takeda Oncology, contributing to her comprehensive understanding of sales dynamics in the healthcare sector.
Education and Professional Development
Ana Merz earned her Master of Business Administration (M.B.A.) from the University of Phoenix. She also completed Texas Executive Education at the Texas McCombs School of Business from 2015 to 2016. Her undergraduate degree is a Bachelor of Science in Marketing from Louisiana State University, obtained from 1995 to 1999.
Achievements in Sales Leadership
Throughout her career, Ana Merz has achieved significant milestones in sales leadership. She successfully launched 12 FDA approvals and 7 indications of IMBRUVICA, which contributed to her team winning Region of the Year twice in five years. Additionally, she has received the Pinnacle Award three times at Pharmacyclics, recognizing her excellence in sales performance.
Mentorship and Training Initiatives
Ana Merz is actively involved in mentorship and training initiatives, focusing on developing the South Region for IMBRUVICA. She participated in the Women's Leadership Journey at AbbVie, where she was one of only 24 individuals selected globally, highlighting her commitment to leadership development and empowerment within the industry.